{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T18:18:18Z","timestamp":1794766698323,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K23HD113841-01A1"],"award-info":[{"award-number":["1K23HD113841-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.josat.2026.210008","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:41:50Z","timestamp":1777610510000},"page":"210008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inpatient initiation of long-acting injectable buprenorphine for adolescents and young adults with opioid use disorder"],"prefix":"10.1016","volume":"188","author":[{"given":"Jayme L.","family":"Congdon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Bazazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Stemmle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherman","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee A.","family":"Trope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.josat.2026.210008_bb0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13722-024-00487-1","article-title":"A case of severe opioid and methamphetamine use disorder in a 14 year old","volume":"19","author":"Allami","year":"2024","journal-title":"Addiction Science & Clinical Practice"},{"issue":"3","key":"10.1016\/j.josat.2026.210008_bb0010","article-title":"Medication-assisted treatment of adolescents with opioid use disorders","volume":"138","author":"American Academy of Pediatrics Committee on Substance Use and Prevention","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.josat.2026.210008_bb0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/JCP.0000000000001195","article-title":"Treating opioid use disorder with a monthly subcutaneous buprenorphine depot injection: 12-Month safety, tolerability, and efficacy analysis","volume":"40","author":"Andorn","year":"2020","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1016\/j.josat.2026.210008_bb0020","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1377\/hlthaff.2022.01513","article-title":"Buprenorphine treatment for opioid use disorder: comparison of insurance restrictions, 2017\u201321","volume":"42","author":"Andraka-Christou","year":"2023","journal-title":"Health Affairs"},{"issue":"6","key":"10.1016\/j.josat.2026.210008_bb0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/ajad.13050","article-title":"A case report: Rapid micro-induction of buprenorphine\/naloxone to administer buprenorphine extended-release in an adolescent with severe opioid use disorder","volume":"29","author":"Azar","year":"2020","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2026.210008_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108494","article-title":"Effectiveness of medication for opioid use disorders in transition-age youth: A systematic review","volume":"132","author":"Becker","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2026.210008_bb0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/ADM.0000000000000388","article-title":"Buprenorphine treatment for adolescents and young adults with opioid use disorders: A narrative review","volume":"12","author":"Borodovsky","year":"2018","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.210008_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jadohealth.2024.04.010","article-title":"Injectable buprenorphine: An opportunity to improve treatment access for youth with opioid use disorder","volume":"75","author":"Calihan","year":"2024","journal-title":"Journal of Adolescent Health"},{"issue":"2","key":"10.1016\/j.josat.2026.210008_bb0045","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1542\/hpeds.2022-006940","article-title":"It is time for pediatric hospitalists to treat opioid use disorder","volume":"13","author":"Camenga","year":"2023","journal-title":"Hospital Pediatrics"},{"issue":"4","key":"10.1016\/j.josat.2026.210008_bb0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.15288\/jsad.2019.80.393","article-title":"Medications for maintenance treatment of opioid use disorder in adolescents: A narrative review and assessment of clinical benefits and potential risks","volume":"80","author":"Camenga","year":"2019","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"12","key":"10.1016\/j.josat.2026.210008_bb0055","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/acem.14782","article-title":"Early emergency department experience with 7-day extended-release injectable buprenorphine for opioid use disorder","volume":"30","author":"D\u2019Onofrio","year":"2023","journal-title":"Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine"},{"key":"10.1016\/j.josat.2026.210008_bb0060","author":"English"},{"key":"10.1016\/j.josat.2026.210008_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209352","article-title":"Engagement, initiation, and retention in medication treatment for opioid use disorder among young adults: A narrative review of challenges and opportunities","volume":"166","author":"Fishman","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"8","key":"10.1016\/j.josat.2026.210008_bb0070","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/add.14636","article-title":"Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder","volume":"114","author":"Frost","year":"2019","journal-title":"Addiction (Abingdon, England)"},{"issue":"10173","key":"10.1016\/j.josat.2026.210008_bb0075","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0140-6736(18)32259-1","article-title":"Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"393","author":"Haight","year":"2019","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.josat.2026.210008_bb0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12954-024-01113-8","article-title":"Opportunities to enhance retention on medication for opioid use disorder for adolescents and young adults: Results from a qualitative study with medical providers in Philadelphia, PA","volume":"21","author":"Herrera","year":"2024","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.josat.2026.210008_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.53771","article-title":"Emergency department access to buprenorphine for opioid use disorder","volume":"7","author":"Herring","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2026.210008_bb0090","series-title":"Sublocade\u00ae (buprenorphine extended-release) package insert","author":"Indivior UK Limited","year":"2025"},{"issue":"2S","key":"10.1016\/j.josat.2026.210008_bb0095","first-page":"1","article-title":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"5","key":"10.1016\/j.josat.2026.210008_bb0100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2024.24121","article-title":"Trends in buprenorphine dispensing among adolescents and young adults in the US","volume":"333","author":"Lee","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2026.210008_bb0105","article-title":"The use of extended-release buprenorphine in the treatment of adolescent opioid use disorder: A case series","author":"Neptune","year":"2024","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2026.210008_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2023.100144","article-title":"Rapid induction onto extended-release injectable buprenorphine following opioid overdose: A case series","volume":"7","author":"Ochalek","year":"2023","journal-title":"Drug and Alcohol Dependence Reports"},{"key":"10.1016\/j.josat.2026.210008_bb0115","first-page":"1","article-title":"Inpatient initiation of long-acting injectable buprenorphine at a community hospital: A retrospective case series","author":"O\u2019Conor","year":"2024","journal-title":"Journal of Addictive Diseases"},{"issue":"3","key":"10.1016\/j.josat.2026.210008_bb0120","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.jadohealth.2024.11.135","article-title":"119. \u201cIt\u2019s really hard to just do it by yourself:\u201d Adolescent perspectives on the facilitators, barriers, and health service preferences to initiating and continuing medication treatment for opioid use disorder","volume":"76","author":"Raney","year":"2025","journal-title":"Journal of Adolescent Health"},{"issue":"9","key":"10.1016\/j.josat.2026.210008_bb0125","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2026.210008_bb0130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jadohealth.2024.01.012","article-title":"Early remission of opioid use disorder in an adolescent using buprenorphine extended - Release subcutaneous injection: A case report","volume":"75","author":"Schmuhl","year":"2024","journal-title":"The Journal of Adolescent Health"},{"key":"10.1016\/j.josat.2026.210008_bb0135","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.josat.2026.210008_bb0140","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1542\/hpeds.2022-006864","article-title":"A novel inpatient buprenorphine induction program for adolescents with opioid use disorder","volume":"13","author":"Trope","year":"2023","journal-title":"Hospital Pediatrics"},{"issue":"4","key":"10.1016\/j.josat.2026.210008_bb0145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/10550887.2023.2251366","article-title":"Buprenorphine: Two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable form","volume":"42","author":"Velagapudi","year":"2024","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.josat.2026.210008_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108306","article-title":"Choice of extended release medication for OUD in young adults (buprenorphine or naltrexone): A pilot enhancement of the Youth Opioid Recovery Support (YORS) intervention","volume":"125","author":"Wenzel","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2026.210008_bb9000","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The Clinical Opiate Withdrawal Scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.josat.2026.210008_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2024.100233","article-title":"Reduced emergency department use among insured individuals receiving extended-release buprenorphine in a health system setting","volume":"11","author":"Yarborough","year":"2024","journal-title":"Drug and Alcohol Dependence Reports"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926001281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926001281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T17:32:17Z","timestamp":1794763937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926001281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"alternative-id":["S2949875926001281"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.210008","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inpatient initiation of long-acting injectable buprenorphine for adolescents and young adults with opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.210008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"210008"}}